ESR1 and breast carcinoma: Breast cancers with high levels of CACNA1H (Cav3.2) (2nd, 3rd, 4th quartile) showed a significant elevation in levels of ESR1 and PGR compared to breast cancers with significantly low levels of Cav3.2 (1st quartile) (Fig. 8b).